AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
AIBOTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00+0.00 (+42.86%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Aibotics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Benjamin Nathaniel Kaplan | CEO, Director | 95,250,000 | 11.20% | Jul 28, 2025 |
| Benjamin Kaplan | CEO, Director | 20,250,000 | 2.38% | Dec 17, 2024 |
| Mark Croskery | Director | 10,016,912 | 1.18% | Dec 17, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Benjamin Nathaniel Kaplan CEO, Director | Jul 25, 2025 | Award | +75,000,000 | – | – | 95,250,000 |
| Mark Croskery Director | Dec 13, 2024 | Award | +10,000,000 | $0.01 | $100.00K | 10,016,912 |
| Benjamin Kaplan CEO, Director | Dec 13, 2024 | Award | +20,000,000 | $0.01 | $200.00K | 20,250,000 |
| Mark D. Williams President, CEO & CFO, Director, 10% owner | Jul 28, 2020 | Award | +500,000 | $50000.00 | $25.00B | 5,946,173 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.